Peer-reviewed veterinary case report
Long-term therapy with deflazacort decreases myocardial fibrosis in mdx mice.
- Journal:
- Muscle & nerve
- Year:
- 2009
- Authors:
- Marques, Maria Julia et al.
- Affiliation:
- Departamento de Anatomia · Brazil
- Species:
- rodent
Abstract
We evaluated the effects of long-term administration of deflazacort (DFZ) on the progression of myocardial fibrosis in mdx mice. Mdx mice (6 months old) were treated with DFZ for 15 months. Myocardial fibrosis (MF) was evaluated by histomorphometric methods, and treated and untreated mdx mice of the same age (21 months) were compared. DFZ significantly decreased MF. We conclude that long-term therapy with DFZ is effective in slowing down the progression of fibrosis in the dystrophin-deficient heart.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/19623634/